I. Blaufarb

Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure.

D. Mancini, G. Jondeau, M. Olivari, 1999, Circulation.

Angiotensin II-receptor blockade further reduces afterload safely in patients maximally treated with angiotensin-converting enzyme inhibitors for heart failure.

D. Mancini, T. LeJemtel, G. Jondeau, 1997, Journal of cardiovascular pharmacology.

beta-blockers. Drug interactions of clinical significance.

W. Frishman, I. Blaufarb, T. M. Pfeifer, 1995, Drug safety.

Clinical benefits of long-term angiotensin II receptor blockade in patients with severe symptoms of congestive heart failure despite full angiotensin converting enzyme inhibition

D. Mancini, T. LeJemtel, G. Jondeau, 1998 .

The effect of aortic stenosis on elderly hip fracture outcomes: A case control study.

Darwin Chen, A. Lovy, C. Moucha, 2016, Injury.

The renin-angiotensin system in left ventricular remodeling.

E. Sonnenblick, I. Blaufarb, 1996, The American journal of cardiology.